Literature DB >> 12215017

Long-term survivors with adult acute leukemia in complete remission: complications and return to work.

Yuhko Suzuki-Tsunoda1, Setsuko Kawamura, Kenichi Tsushima, Yoshiko Tamai, Hideki Takami, Akihiro Munakata, Masashi Tsunoda.   

Abstract

For addressing, and eventually being able to predict and prevent, both disease-related complications and changes in social status in long-term acute leukemia survivors, the follow-up is the most important factor after treatment. To this end, we assessed the complications following the attainment of complete remission in adult acute leukemia patients and the changes in social status of patients surviving more than 5 years after disease onset. In our study population of 42 survivors, 24 (57.1%) suffered from various combinations of 18 types of identified complications including posttransfusion hepatitis, diabetes mellitus, and idiopathic osteonecrosis. Regarding fertility, 9 live births were recorded in this cohort, from 2 female patients and the partner of a male patient. Of these 42 long-term survivors, at the time of this report 48.5% were working full- or part-time, 9.0% were unemployed, 30.3% were homemakers, and 12.2% were retired.

Entities:  

Mesh:

Year:  2002        PMID: 12215017     DOI: 10.1007/BF02982581

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  34 in total

1.  [Favorable prognoses in 24 adult patients with acute leukemia, surviving over five years since 1985].

Authors:  S Kawamura; Y Tamai; Y Konuma; K Fukushima; H Takami; K Tsushima; Y Sakata; Y Yoshida; Y Sawada
Journal:  Rinsho Ketsueki       Date:  1992-07

Review 2.  The incidence of secondary leukemias.

Authors:  G Leone; L Mele; A Pulsoni; F Equitani; L Pagano
Journal:  Haematologica       Date:  1999-10       Impact factor: 9.941

3.  Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.

Authors:  M Watson; K Wheatley; G A Harrison; R Zittoun; R G Gray; A H Goldstone; A K Burnett
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

4.  The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.

Authors:  H Ohnuma; T Tanaka; A Yoshikawa; H Murokawa; K Minegishi; R Yamanaka; H Y Lizuka; M Miyamoto; S Satoh; S Nakahira; T Tomono; T Murozuka; Y Takeda; Y Doi; H Mine; S Yokoyama; T Hirose; K Nishioka
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

5.  Chronic hepatitis C virus infections in leukemia survivors: prevalence, viral load, and severity of liver disease.

Authors:  I M Paul; J Sanders; F Ruggiero; T Andrews; D Ungar; M E Eyster
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

Review 6.  Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.

Authors:  M Okuno; S Kojima; H Moriwaki
Journal:  J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 4.029

7.  Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis.

Authors:  S Takano; K Nakamura; S Kawai; O Yokosuka; Y Satomura; M Omata
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

8.  Bone mineral density in long-term survivors of childhood cancer.

Authors:  P B Hesseling; S F Hough; E D Nel; F A van Riet; T Beneke; G Wessels
Journal:  Int J Cancer Suppl       Date:  1998

9.  Gynecological abnormalities following allogeneic bone marrow transplantation.

Authors:  M A Schubert; K M Sullivan; M M Schubert; J Nims; M Hansen; J E Sanders; J O'Quigley; R P Witherspoon; C D Buckner; R Storb
Journal:  Bone Marrow Transplant       Date:  1990-06       Impact factor: 5.483

Review 10.  Bone marrow transplant nephropathy: radiation nephritis revisited.

Authors:  E P Cohen; C A Lawton; J E Moulder
Journal:  Nephron       Date:  1995       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.